Condition

Geographic Atrophy Secondary to Age-related Macular Degeneration clinical trials and research

• 9Clinical trials
• 24Countries

Newest Geographic Atrophy Secondary to Age-related Macular Degeneration clinical trials

All recruiting trials (9)

• See if RO7965032 helps geographic atrophy from AMD

  This trial tests RO7965032 versus placebo to see if it can help people with geographic atrophy due to age-related macular degeneration.

  Recruiting at 5 sites Phase 2 Genentech, Inc. · Walnut Creek, California and 4 other locations · NCT07851259

• Transcorneal electrical stimulation to slow geographic atrophy

  This study will see if weekly at-home transcorneal electrical stimulation with the OkuStim 2 device can slow vision loss in people aged 60 and older with geographic atrophy from age-related macular degeneration.

  Recruiting at 4 sites Okuvision GmbH · Hamburg and 4 other locations · NCT07531927

• FWY003 versus placebo for geographic atrophy from age-related macular degeneration

  This study will test whether injections of FWY003 can slow the growth of geographic atrophy in people aged 50 and older with AMD.

  Recruiting at 65 sites Phase 2 Novartis · Huntington Beach, California and 64 other locations · NCT07441642

• One-time subretinal CTx001 injection for geographic atrophy from AMD

  This trial will try a single subretinal injection of CTx001 to see if it is safe and helps people with bilateral geographic atrophy from age-related macular degeneration.

  Recruiting at 8 sites Phase 1/2 Complement Therapeutics · Carmel, Indiana and 7 other locations · NCT07392255

• APL-3007 combined with Syfovre (pegcetacoplan) for geographic atrophy from age-related macular degeneration

  This trial will test whether adding APL-3007 to ongoing Syfovre (pegcetacoplan) injections can slow geographic atrophy progression in people aged 60 and older already receiving Syfovre.

  Recruiting at 78 sites Phase 2 Apellis Pharmaceuticals, Inc. · Gilbert, Arizona and 77 other locations · NCT07215390

• Short-term progression of geographic atrophy in people with age-related macular degeneration

  See how geographic atrophy changes over a short time in people aged 55 and older who have dry AMD.

  Recruiting at 17 sites Complement Therapeutics · Mountain View, California and 18 other locations · NCT07144137

• ADX-038 for geographic atrophy due to age-related macular degeneration

  This phase 2 study will test whether ADX-038 can slow geographic atrophy in people with age-related macular degeneration compared with placebo while monitoring safety and drug levels.

  Recruiting at 40 sites Phase 2 ADARx Pharmaceuticals, Inc. · Gilbert, Arizona and 82 other locations · NCT06990269

• Evaluating KRIYA-825 for treating geographic atrophy in older adults

  This study is testing a new treatment called KRIYA-825 to see if it can safely help older adults with geographic atrophy from age-related macular degeneration by slowing down the growth of eye lesions.

  Recruiting at 4 sites Phase 1/2 Kriya Therapeutics, Inc. · Erie, Pennsylvania and 3 other locations · NCT06765980

• Microcurrent therapy for advanced age-related macular degeneration

  This study is testing a new device that uses microcurrents to see if it can improve vision and eye health in people with advanced age-related macular degeneration.

  Recruiting at 11 sites i-Lumen Scientific AUS PTY LTD · Poway, California and 12 other locations · NCT06662162

Related topics

Quick answers

How many Geographic Atrophy Secondary to Age-related Macular Degeneration clinical trials are recruiting right now?

9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 24 countries. The most sites are in United States (8 trials), United Kingdom (5 trials), Australia (3 trials), Canada (3 trials), Germany (3 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4, Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →